Dana Investment Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-8,196
Closed -$1.78M 420
2023
Q1
$1.78M Buy
8,196
+1,547
+23% +$301K 0.09% 152
2022
Q4
$1.37M Buy
6,649
+1,123
+20% +$284K 0.07% 196
2022
Q3
$1.54M Sell
5,526
-2,862
-34% -$728K 0.09% 154
2022
Q2
$1.6M Sell
8,388
-441
-5% -$77.8K 0.08% 159
2022
Q1
$1.83M Buy
8,829
+446
+5% +$73.5K 0.08% 142
2021
Q4
$1.5M Buy
+8,383
New +$1.65M 0.06% 184

Other funds holding SWAV

Dana Investment Advisors's SWAV Position: Q2 2023 in Review

Dana Investment Advisors sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2023, closing a stake of 8,196 shares — an estimated $1.78M sold.

Dana Investment Advisors first reported a position in SWAV in Q4 2021 and held it in 6 quarters. The position peaked at $1.83M in Q1 2022. 460 funds tracked by Wall St. Rank hold SWAV as of Q2 2023.

  • Dana Investment Advisors reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Dana Investment Advisors sold 8,196 Shockwave Medical, Inc. Common Stock shares in Q2 2023, an estimated $1.78M.
  • Dana Investment Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Dana Investment Advisors's Shockwave Medical, Inc. Common Stock position peaked at $1.83M in Q1 2022.
  • 460 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2023.

Based on Dana Investment Advisors's 13F filing for Q2 2023, filed 15 Aug 2023.